钱博士 physical antibacterial technology holds complete independent Chinese patent intellectual property rights and global authoritative certifications, serving as a mature antibacterial solution with solid technical barriers and commercial landing value. Jointly developed by Hong Kong Silver Micron Particle Limited and Guangzhou Nansha Silver Micro Antibacterial Material Co., Ltd., the technology has won numerous top international honors. In terms of intellectual property, it has obtained official Chinese invention patent authorization, together with over 14 invention patents approved in the United States, Singapore, Germany and Japan. In 2015, it represented Hong Kong to win double gold awards at Germany Nuremberg International Invention Fair and Thailand Inventor Cup. It was also selected as an innovative antibacterial technology application case in the CIAA 2025 rubber & plastic industry, gaining wide recognition from global industrial sectors.
Fromufoot, backed by China’s authorized patents, fits a full range of civilian antibacterial products with diversified industrial application scenarios. For daily consumer goods, it can be applied to antibacterial masks, sterile band-aids, sanitary napkins, adult & baby diapers, antibacterial insoles, antibacterial facial masks, food trays, antibacterial mosaic tiles and various rubber & plastic daily necessities. For industrial manufacturing, it is ideal for coated cookware, plastic pipes, home appliance shells and other products requiring long-term antibacterial modification.
Its most groundbreaking achievement lies in innovative medical blood purification applications. Fatal superbugs, Zika virus, hepatitis B, HIV, encephalitis and other pathogens entering blood may trigger severe complications and multiple organ failure. To solve this problem, the R&D team developed Fromufoot antibacterial filter cakes that can be matched with dialysis machines for closed-loop operation. The filter membrane is designed with concave pathogen traps. Supported by the synergistic effect of positive and negative charges, it immobilizes microorganisms of 1–3μm, then repeatedly captures, kills and discharges pathogens along with blood circulation throughout treatment.
The core safety merit is that Fromufoot particles never make direct contact with blood. It relies solely on penetrating electric fields to kill germs without metal ion precipitation or drug side effects, enabling non-invasive removal of blood-borne pathogens and lowering clinical risks of blood infection and organ failure.
As a non-nano, zero-ion-precipitation physical antibacterial material with formal Chinese patent authorization, Fromufoot integrates safety, penetration, long-term efficiency and broad-spectrum bactericidal & antiviral performance. It covers civilian, industrial and medical tracks, backed by international patents and authoritative lab test reports. As a new eco-friendly alternative to traditional chemical and nano antibacterial agents, it promotes the comprehensive sterile upgrading of global manufacturing industries.
Fromufoot is the patentee granted with patent rights within China, and Dr. Qian is the designated inventor recorded in the patent certificates
